Skip to content
Saturday, October 17, 2026
IonSpot UK

Patients Discontinuing Weight-Loss Injections Put On Weight Four Times Faster Than Dieters

Illustration of medical injection and scale
Weight management often requires long-term strategies.

A recent study reveals that patients who stop using popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who stop conventional lifestyle regimens.

Research printed in a leading medical journal demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Users purchasing these drugs must be informed of the risk of rapid rebound weight gain when the therapy is stopped," warns researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to original weight within about one and a half years.

Weighing Therapies

The analysis, which reviewed dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with conventional dieting.

Scientists point out that people who lose weight through dieting generally have a slower weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Fast Regain

Experts believe the mode of action of the jabs explains the amplified weight return.

These medications imitate a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement means hunger is no longer kept in check, making overeating much more probable."

A Lifelong Condition?

Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, given the significant potential of weight regain, the treatment is often life-long.

This perspective is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term character of excess weight," similar to managing diseases like diabetes.

Patient Testimonies

People who have stopped the jabs report a intense return of cravings.

"It was like something that goes on and I was suddenly extremely hungry," described an individual.

This challenge is exacerbated if patients have not adopted lasting lifestyle or habit modifications during treatment.

Widespread Adoption

Recent estimates suggest that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.

  • Adoption is more common among females than males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are powerful tools for weight loss, they are not a magic fix and maintained weight loss likely depends on integrated lifestyle management.

MG
About the author

Michelle Gonzalez

A tech journalist and industry analyst with over a decade of experience covering emerging technologies and digital innovation.

IonSpot UK

Type to search articles.